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See related research by Kim et al., http://www.ccforum.com/content/19/1/350Acute kidney injury (AKI) is a common complication
associated with increased morbidity and mortality in
cardiac surgery patients. In this context, the recent paper
by Kim et al., showing that a peri-operative liberal
‘saline- and starch-based’ fluid management significantly
enhanced the incidence of severe post-operative AKI in
off-pump cardiac surgery patients, is to be acclaimed [1].
With regard to the potential culprit(s) triggering this
AKI, the authors pointed at ‘usual suspects’ such as ex-
cess chloride and intrinsic starch-induced renal tubular
lesions. However, it is noteworthy that patients in the at-
risk group were less likely (p = 0.001!) to be receiving
statins before surgery [1]. Statins may prevent kidney in-
jury through inhibition of post-operative inflammatory
processes. Compared with statin-naive subjects, cardiac
surgery patients taking statins indeed had reduced levelsAuthors’ response
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alpha, myeloperoxidase, and pro-inflammatory interleu-
kin (IL)-1, IL-6, and IL-8 and higher concentrations of
the anti-inflammatory IL-10 [2]. The largest meta-
analysis to date, including nearly 60,000 cardiac surgery
patients, revealed a 13 % reduction of post-operative
AKI in patients pre-operatively treated with statins [3].
Whether statins embrace the kidney as friend or foe is
debatable but probably depends upon the type of study
cohort (e.g. septic vs. non-septic), the intervention (e.g.
surgery), and pre-existing chronic kidney disease. For ex-
ample, agent-dependent ‘high potency’ statin doses in-
crease the risk of AKI in a general patient population [4]
whereas the use of corresponding high doses in cardiac
surgery patients appears to exhibit a reno-protective
effect [5].We thank Professor Honore and colleagues for their
interest in our article [1] and their comment. Statin has
been widely used in patients with cardiovascular disor-
ders. We agree that the patients in the control group
were less likely to be receiving statin before the surgery,
which could have affected our results. However, al-
though some clinical studies have suggested a reno-
protective effect of statin in patients undergoing cardiac
surgery [6, 7], there is a lack of evidence to support thebeneficial effect of pre-operative statin on renal function
after cardiac surgery. Previous studies have reported that
pre-operative statin therapy is not associated with a re-
duced incidence of post-operative AKI [8], including
after cardiac surgery [9]. Nevertheless, we tested the im-
pact of pre-operative statin treatment on our results. Al-
though pre-operative statin treatment was not associated
with post-operative AKI (odds ratio 0.95 (95 % confidence
interval 0.65–1.39), p = 0.78) in a univariate analysis, weis distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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Honore et al. Critical Care  (2015) 19:453 Page 2 of 2forced the variable into the final model and there was still
a significant association between the renal protective fluid
management strategy and post-operative AKI (odds ratio
0.23 (95 % confidence interval 0.14–0.36), p <0.001). We
can therefore definitely conclude that statins had no sig-
nificant role to play in our observations.
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